SK3632002A3 - Piperidine quinolyl propyl derivatives, preparation method and compositions containing same - Google Patents

Piperidine quinolyl propyl derivatives, preparation method and compositions containing same Download PDF

Info

Publication number
SK3632002A3
SK3632002A3 SK363-2002A SK3632002A SK3632002A3 SK 3632002 A3 SK3632002 A3 SK 3632002A3 SK 3632002 A SK3632002 A SK 3632002A SK 3632002 A3 SK3632002 A3 SK 3632002A3
Authority
SK
Slovakia
Prior art keywords
propyl
piperidine
methoxyquinolin
acetic acid
group
Prior art date
Application number
SK363-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Jean-Luc Malleron
Michel Tabart
Jean-Christophe Carry
Michel Evers
Ahmad Youssef El
Serge Mignani
Fabrice Viviani
Michel Cheve
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of SK3632002A3 publication Critical patent/SK3632002A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SK363-2002A 1999-09-17 2000-09-14 Piperidine quinolyl propyl derivatives, preparation method and compositions containing same SK3632002A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9911679A FR2798656B1 (fr) 1999-09-17 1999-09-17 Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent
PCT/FR2000/002541 WO2001025227A2 (fr) 1999-09-17 2000-09-14 Derives de la quinolyl propyl piperidine et leur utilisation en tant que antibacteriens

Publications (1)

Publication Number Publication Date
SK3632002A3 true SK3632002A3 (en) 2003-04-01

Family

ID=9549990

Family Applications (1)

Application Number Title Priority Date Filing Date
SK363-2002A SK3632002A3 (en) 1999-09-17 2000-09-14 Piperidine quinolyl propyl derivatives, preparation method and compositions containing same

Country Status (30)

Country Link
EP (2) EP1218370B1 (sh)
JP (1) JP2004527448A (sh)
KR (1) KR20020038757A (sh)
CN (1) CN1374959A (sh)
AP (1) AP2002002459A0 (sh)
AT (1) ATE284399T1 (sh)
AU (1) AU7429500A (sh)
BG (1) BG106524A (sh)
BR (1) BR0014060A (sh)
CA (1) CA2383836A1 (sh)
CZ (1) CZ2002940A3 (sh)
DE (2) DE60016611T2 (sh)
DZ (1) DZ3195A1 (sh)
EA (1) EA005183B1 (sh)
EE (1) EE200200138A (sh)
FR (1) FR2798656B1 (sh)
GE (1) GEP20043223B (sh)
HR (1) HRP20020214A2 (sh)
HU (1) HUP0204283A3 (sh)
IL (1) IL148720A0 (sh)
MA (1) MA26820A1 (sh)
MX (1) MXPA02001979A (sh)
NO (1) NO20021253L (sh)
OA (1) OA12022A (sh)
PL (1) PL354809A1 (sh)
SK (1) SK3632002A3 (sh)
TN (1) TNSN00184A1 (sh)
WO (1) WO2001025227A2 (sh)
YU (1) YU19002A (sh)
ZA (1) ZA200202073B (sh)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9822440D0 (en) 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
GB9917408D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
GB9917406D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
CZ2003243A3 (cs) 2000-07-26 2003-09-17 Smithkline Beecham P. L. C. Aminopiperidinové chinoliny a jejich azaisosterické analogy s antibakteriální aktivitou
GB0031086D0 (en) * 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
WO2003064431A2 (en) 2002-01-29 2003-08-07 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
EP1470125A1 (en) 2002-01-29 2004-10-27 Glaxo Group Limited Aminopiperidine derivatives
AR040336A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
FR2842807A1 (fr) 2002-07-23 2004-01-30 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, procede et intermediaires de preparation et compositions les renfermant
FR2844270B1 (fr) 2002-09-11 2006-05-19 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
FR2844268B1 (fr) * 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
WO2004035569A2 (de) * 2002-10-10 2004-04-29 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue verbindungen mit antibakterieller aktivität
ATE479683T1 (de) 2002-11-05 2010-09-15 Glaxo Group Ltd Antibakterielle mittel
DE60331849D1 (de) 2002-11-05 2010-05-06 Glaxosmithkline Llc Antibakterielle wirkstoffe
AU2003294565A1 (en) 2002-12-04 2004-06-23 Glaxo Group Limited Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
EP1799674B1 (en) * 2004-10-05 2010-05-05 Actelion Pharmaceuticals Ltd. New piperidine antibiotics
WO2006038172A1 (en) * 2004-10-05 2006-04-13 Actelion Pharmaceuticals Ltd New piperidine antibiotics
US7648980B2 (en) 2005-01-25 2010-01-19 Glaxo Group Limited Antibacterial agents
US7709472B2 (en) 2005-01-25 2010-05-04 Glaxo Group Limited Antibacterial agents
JP2008528598A (ja) 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
EP1846418A4 (en) 2005-01-25 2009-12-23 Glaxo Group Ltd ANTIBACTERIAL ACTIVE SUBSTANCES
CA2635126A1 (en) 2006-01-26 2007-08-02 Actelion Pharmaceuticals Ltd Tetrahydropyrane antibiotics
WO2007115947A1 (en) 2006-04-06 2007-10-18 Glaxo Group Limited Pyrrolo-quinoxalinone derivatives as antibacterials
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
MX2009012117A (es) * 2007-05-09 2009-11-23 Pfizer Composiciones y derivados heterociclicos sustituidos y su uso farmaceutico como antibacterianos.
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
WO2010043714A1 (en) 2008-10-17 2010-04-22 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
ES2561631T3 (es) 2009-01-15 2016-02-29 Glaxo Group Limited Compuestos de naftiridin-2(1H)-ona útiles como agentes antibacterianos
CN105636945B (zh) * 2013-10-14 2017-11-17 卫材R&D管理有限公司 选择性取代的喹啉化合物
JP6546654B2 (ja) 2014-08-22 2019-07-17 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited 淋菌感染を治療するための三環式含窒素化合物
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
CA3005766A1 (en) 2015-12-17 2017-06-22 Merck Patent Gmbh Polycyclic tlr7/8 antagonists and use thereof in the treatment of immune disorders
JP7125385B2 (ja) 2016-08-08 2022-08-24 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング Tlr7/8アンタゴニストおよびそれらの使用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69908555T2 (de) * 1998-01-26 2004-05-06 Smithkline Beecham P.L.C., Brentford Chinolinderivate als antibakterielles arzneimittel
EP1144404A1 (en) * 1999-01-20 2001-10-17 Smithkline Beecham Plc Piperidinylquinolines as protein tyrosine kinase inhibitors

Also Published As

Publication number Publication date
NO20021253D0 (no) 2002-03-13
EA005183B1 (ru) 2004-12-30
WO2001025227A3 (fr) 2001-11-22
DE60016611T2 (de) 2005-12-22
HRP20020214A2 (en) 2005-04-30
EP1218370B1 (fr) 2004-12-08
IL148720A0 (en) 2002-09-12
MA26820A1 (fr) 2004-12-20
JP2004527448A (ja) 2004-09-09
AP2002002459A0 (en) 2002-06-30
DE60034713T2 (de) 2008-01-17
GEP20043223B (en) 2004-04-26
KR20020038757A (ko) 2002-05-23
EP1218370A2 (fr) 2002-07-03
DE60034713D1 (de) 2007-06-14
FR2798656B1 (fr) 2004-12-17
BG106524A (en) 2003-01-31
DE60016611D1 (de) 2005-01-13
OA12022A (fr) 2006-04-19
NO20021253L (no) 2002-04-24
CN1374959A (zh) 2002-10-16
AU7429500A (en) 2001-05-10
PL354809A1 (en) 2004-02-23
ZA200202073B (en) 2003-08-27
EA200200374A1 (ru) 2002-10-31
EP1484328A1 (fr) 2004-12-08
WO2001025227A2 (fr) 2001-04-12
BR0014060A (pt) 2002-05-21
TNSN00184A1 (fr) 2005-11-10
HUP0204283A3 (en) 2004-07-28
EE200200138A (et) 2003-06-16
YU19002A (sh) 2005-06-10
CA2383836A1 (fr) 2001-04-12
MXPA02001979A (es) 2002-08-20
HUP0204283A2 (hu) 2003-04-28
EP1484328B1 (fr) 2007-05-02
CZ2002940A3 (cs) 2002-07-17
DZ3195A1 (fr) 2001-04-12
FR2798656A1 (fr) 2001-03-23
ATE284399T1 (de) 2004-12-15

Similar Documents

Publication Publication Date Title
SK3632002A3 (en) Piperidine quinolyl propyl derivatives, preparation method and compositions containing same
US6403610B1 (en) Quinolylpropylpiperidine derivatives, their preparation and the compositions which comprise them
AU2018267569B2 (en) Bicyclic heterocyclyl derivatives as IRAK4 inhibitors
US6602884B2 (en) Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them
EP2945938B1 (en) 3-substituted pyrazoles and use as dlk inhibitors
AU2016224974B2 (en) Substituted pyrazole compounds as serine protease inhibitors
AU2002253219B8 (en) Quinolyl propyl piperidine derivatives, the preparation thereof and compositions containing same
US7622471B2 (en) Pyrazole derivatives having a pyridazine and pyridine functionality
SK5822003A3 (en) Heterocylcylalkyl piperidine derivatives and their use as antimicrobial agents
WO2006126676A1 (ja) 置換アルキル基を有する環状アミン誘導体
WO2005051913A1 (ja) ヘテロアリール環を有する環状アミン誘導体
AU2003278297A1 (en) Quinolylpropylpiperidine derivatives and use thereof as antimicrobial agents
JP2008540575A (ja) 多環系化合物とその使用の方法
JP2002521382A (ja) ロータマーゼ酵素の阻害薬としてのヘテロ環式化合物
EP0307141A2 (en) Oxazoles and thiazoles for the treatment of senile dementia
EP1831194A1 (en) HETEROCYCLIC MCHr1 ANTAGONISTS AND THEIR USE IN THERAPY
TWI475021B (zh) 新穎(雜環-四氫吡啶)(哌基)-1-烷酮及(雜環-二氫吡咯啶)(哌基)-1-烷酮衍生物及其作為p75抑制劑之用途
TW202241858A (zh) 適用於治療血脂異常之新穎化合物
US12565494B2 (en) Inhibitors of human respiratory syncytial virus and metapneumovirus
KR20220152159A (ko) 신규한 헤테로사이클 화합물 및 이의 용도